Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

GABA-WHY Study: Deprescription of Gabapentinoids in Medical Inpatients

NCT04855578 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT04855578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04855578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
GABA-WHY Study: Deprescription of Gabapentinoids in Medical Inpatients
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Not applicable
Overall status
Completed
Start date
May 28, 2021
Completion date
December 7, 2023
Enrollment
160 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gabapentin, polypharmacy, pregabalin